PEISERT DANIEL A. (SVP and CFO) purchased 89.0% of their position (19K shares) of ASSERTIO THERAPEUTICS, INC on the open market
Open‑market purchase worth $29.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/12/2019ACC: 0001005201-19-000097
Officer· SVP and CFO
Since Dec 2018
+19K
Net shares
Net buyer
$29.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
19K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.90K
Price / share
$1.54
Trade value
$2.93K
% of position
8.9%
8/12/2019
21.36K→23.26K
Common Stock
Direct
Shares
+17.10K
Price / share
$1.57
Trade value
$26.85K
% of position
73.5%
8/12/2019
23.26K→40.36K
Total
Net shares
+19K
Net value
$29.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2019 | P · Purchase | +1.90K | $1.54 | $2.93K | 8.9% | 21.36K | 23.26K |
| Common Stock Direct | 8/12/2019 | P · Purchase | +17.10K | $1.57 | $26.85K | 73.5% | 23.26K | 40.36K |
| Total | +19K | $29.77K | ||||||
Derivative Transactions0
No derivative transactions reported